← Back to Clinical Trials
Recruiting NCT06194838

NCT06194838 Clinical Outcomes With Non-Powered vs. Powered Prosthetic Knees by K2-level Amputees

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06194838
Status Recruiting
Phase
Sponsor Liberating Technologies, Inc.
Condition Amputation
Study Type INTERVENTIONAL
Enrollment 26 participants
Start Date 2023-09-12
Primary Completion 2026-08-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Ossur Power KneeReboocon Intuy Knee

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 26 participants in total. It began in 2023-09-12 with a primary completion date of 2026-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this proposed project is to gather community-based data from the K2-level Transfemoral Amputee (TFA) population to aid in evidence-based prescription of powered prosthetic knees (i.e., choosing the right device to maximize the benefit for each patient). The investigators intend to use this trial data along with a concurrent study being conducted within the K3-K4 level population to guide the implementation of effective prescriptions towards those that can benefit most from a given device and limit prescription to those who would not see benefit in order to ensure the most judicious use of Department of Defense (DoD) and Veteran's Affairs healthcare dollars. The findings will also be shared with the research community to help drive the design of future devices by identifying what features and functions are most beneficial to which patient populations when the devices are used outside of the laboratory. In summary, more community-based data on how powered prosthetic knees compare with the current standard in TFA populations is needed to allow for improved clinical decision making and clinical outcomes.

Eligibility Criteria

Inclusion Criteria: * Are at least 18 years old * Transfemoral prosthesis user (limb absence between the knee and hip) * Current user of a mechanical knee * Regularly wears prosthesis at least 5 days per week * Have adequate clearance between distal end and ground for necessary knee and foot components * Current Medicare Functional Classification Level (K-Level) of 2 as determined by the healthcare team * Socket-Comfort Score: 6 or above to ensure adequate socket fit * Six months or more experience on a prosthesis * Body weight between 50kg and 116kg (110lbs - 256lbs) * Height between 1.2m and 1.95m (47.2in and 76.8in) * Has a phone to answer periodic study calls Exclusion Criteria: * Present injuries to residual limb or contralateral leg affecting functional ability * Contralateral amputation proximal to MTP (metatarsophalangeal) joint * Socket issues/changes in the last 6 weeks * Users with bone-anchored implants * Health or medical condition, diagnosis, or other cause that would prevent participant from effectively following study protocol, performing required outcome measures, and/or completing the study Subjects can be excluded at the discretion of the investigator for other unforeseen disqualifying criteria (such as specific cognitive issues, etc.). If subjects experience a health or medical condition that leaves them immobile for more than 2 weeks, they may be given the option to restart the study condition upon recovery, as long as eligibility criteria is still met, and comparable baseline functionality is demonstrated with outcomes measures. Using a knee that the subject is unfamiliar with may increase the risk of falling. Therefore, pregnant women should not participate in the study and will be screened by self-disclosure.

Contact & Investigator

Central Contact

Shane Wurdeman, PhD

✉ swurdeman@hanger.com

📞 402-290-8051

Principal Investigator

Jennifer Johansson, MS

PRINCIPAL INVESTIGATOR

Liberating Technologies, Inc.

Frequently Asked Questions

Who can join the NCT06194838 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Amputation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06194838 currently recruiting?

Yes, NCT06194838 is actively recruiting participants. Contact the research team at swurdeman@hanger.com for enrollment information.

Where is the NCT06194838 trial being conducted?

This trial is being conducted at Austin, United States.

Who is sponsoring the NCT06194838 clinical trial?

NCT06194838 is sponsored by Liberating Technologies, Inc.. The principal investigator is Jennifer Johansson, MS at Liberating Technologies, Inc.. The trial plans to enroll 26 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology